<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="cs_anchor() can be used to determine the clinical significance
of intervention studies employing the anchor-based approach. For this, a
predefined minimally important difference (MID) for an instrument is known
that corresponds to an important symptom improvement for patients. The data
can then be analyzed on the individual as well as the group level to
estimate, if the change because of an intervention is clinically
significant."><title>Anchor-Based Analysis of Clinical Significance — cs_anchor • clinicalsignificance</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Anchor-Based Analysis of Clinical Significance — cs_anchor"><meta property="og:description" content="cs_anchor() can be used to determine the clinical significance
of intervention studies employing the anchor-based approach. For this, a
predefined minimally important difference (MID) for an instrument is known
that corresponds to an important symptom improvement for patients. The data
can then be analyzed on the individual as well as the group level to
estimate, if the change because of an intervention is clinically
significant."><meta property="og:image" content="/logo.png"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">clinicalsignificance</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.2.1.9010</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/anchor-based-approach.html">Anchor-Based Approaches</a>
    <a class="dropdown-item" href="../articles/combined-approach.html">Combined Approach</a>
    <a class="dropdown-item" href="../articles/distribution-based-approach.html">Distribution-Based Approach</a>
    <a class="dropdown-item" href="../articles/percentage-change-approach.html">Percentage-Change Approach to Clinical Significance in R</a>
    <a class="dropdown-item" href="../articles/statistical-approach.html">Statistical Approach</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/pedscience/clinicalsignificance/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Anchor-Based Analysis of Clinical Significance</h1>
      <small class="dont-index">Source: <a href="https://github.com/pedscience/clinicalsignificance/blob/HEAD/R/cs_anchor.R" class="external-link"><code>R/cs_anchor.R</code></a></small>
      <div class="d-none name"><code>cs_anchor.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p><code>cs_anchor()</code> can be used to determine the clinical significance
of intervention studies employing the anchor-based approach. For this, a
predefined minimally important difference (MID) for an instrument is known
that corresponds to an important symptom improvement for patients. The data
can then be analyzed on the individual as well as the group level to
estimate, if the change because of an intervention is clinically
significant.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">cs_anchor</span><span class="op">(</span></span>
<span>  <span class="va">data</span>,</span>
<span>  <span class="va">id</span>,</span>
<span>  <span class="va">time</span>,</span>
<span>  <span class="va">outcome</span>,</span>
<span>  <span class="va">group</span>,</span>
<span>  pre <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  post <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  mid_improvement <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  mid_deterioration <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  better_is <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"lower"</span>, <span class="st">"higher"</span><span class="op">)</span>,</span>
<span>  target <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"individual"</span>, <span class="st">"group"</span><span class="op">)</span>,</span>
<span>  effect <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"within"</span>, <span class="st">"between"</span><span class="op">)</span>,</span>
<span>  bayesian <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  prior_scale <span class="op">=</span> <span class="st">"medium"</span>,</span>
<span>  reference_group <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  ci_level <span class="op">=</span> <span class="fl">0.95</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>data</dt>
<dd><p>A tidy data frame</p></dd>


<dt>id</dt>
<dd><p>Participant ID</p></dd>


<dt>time</dt>
<dd><p>Time variable</p></dd>


<dt>outcome</dt>
<dd><p>Outcome variable</p></dd>


<dt>group</dt>
<dd><p>Grouping variable (optional)</p></dd>


<dt>pre</dt>
<dd><p>Pre measurement (only needed if the time variable contains more
than two measurements)</p></dd>


<dt>post</dt>
<dd><p>Post measurement (only needed if the time variable contains more
than two measurements)</p></dd>


<dt>mid_improvement</dt>
<dd><p>Numeric, change that indicates a clinically
significant improvement</p></dd>


<dt>mid_deterioration</dt>
<dd><p>Numeric, change that indicates a clinically
significant deterioration (optional). If <code>mid_deterioration</code> is not
provided, it will be assumed to be equal to <code>mid_improvement</code></p></dd>


<dt>better_is</dt>
<dd><p>Which direction means a better outcome for the used
instrument? Available are</p><ul><li><p><code>"lower"</code> (lower outcome scores are desirable, the default) and</p></li>
<li><p><code>"higher"</code> (higher outcome scores are desirable)</p></li>
</ul></dd>


<dt>target</dt>
<dd><p>String, whether an individual or group analysis should be
calculated. Available are</p><ul><li><p><code>"individual"</code> (the default) for which every individual participant is
evaluated</p></li>
<li><p><code>"group"</code> for which only the group wise effect is evaluated</p></li>
</ul></dd>


<dt>effect</dt>
<dd><p>String, if <code>target = "group"</code>, specify which effect should be
calculated. Available are</p><ul><li><p><code>"within"</code> (the default), which yields the mean pre-post intervention
difference with associated confidence intervals</p></li>
<li><p><code>"between"</code>, which estimates the group wise mean difference and
confidence intervals between two or more groups specified with the <code>group</code>
argument at the specified measurement supplied with the <code>post</code>- argument
The reference group may be supplied with <code>reference_group</code></p></li>
</ul></dd>


<dt>bayesian</dt>
<dd><p>Logical, only relevant if <code>target = "group"</code>. Indicates if a
Bayesian estimate (i.e., the median) of group differences with a credible
interval should be calculated (if set to <code>TRUE</code>, the default) or a
frequentist mean difference with confidence interval (if set to <code>FALSE</code>)</p></dd>


<dt>prior_scale</dt>
<dd><p>String or numeric, can be adjusted to change the Bayesian
prior distribution. See the documentation for <code>rscale</code> in
<code><a href="https://rdrr.io/pkg/BayesFactor/man/ttestBF.html" class="external-link">BayesFactor::ttestBF()</a></code> for details.</p></dd>


<dt>reference_group</dt>
<dd><p>Specify the reference group to which all subsequent
groups are compared against if <code>target = "group"</code> and <code>effect = "within"</code>
(optional). Otherwise, the first distinct group is chosen based on
alphabetical, numerical or factor ordering.</p></dd>


<dt>ci_level</dt>
<dd><p>Numeric, define the credible or confidence interval level.
The default is 0.95 for a 95%-CI.</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    

<p>An S3 object of class <code>cs_analysis</code> and <code>cs_anchor</code></p>


    </div>
    <div class="section level2">
    <h2 id="computational-details">Computational details<a class="anchor" aria-label="anchor" href="#computational-details"></a></h2>
    <p>For the individual-level analyses, the
analysis is straight forward. An MID can be specified for an improvement as
well as a deterioration (because these must not necessarily be identical)
and the function basically counts how many patients fall within the MID
range for both, improvement and deterioration, or how many patients exceed
the limits of this range in either direction. A patient may than be
categorized as:</p><ul><li><p>Improved, the patient demonstrated a change that is equal or greater then
the MID for an improvement</p></li>
<li><p>Unchanged, the patient demonstrated a change that is less than both MIDs</p></li>
<li><p>Deteriorated, the patient demonstrated a change that is equal or greater
then the MID for a deterioration</p></li>
</ul><p>For group-level analyses, the whole sample is either treated as a single
group or is split up by grouping presented in the data. For within group
analyses, the function calculates the median change from pre to post
intervention with the associated credible interval (CI). Based on the
median change and the limits of this CI, a group change can be categorized
in 5 distinctive categories:</p><ul><li><p>Statistically not significant, the CI contains 0</p></li>
<li><p>Statistically significant but not clinically relevant, the CI does not
contain 0, but the median and both CI limits are beneath the MID threshold</p></li>
<li><p>Not significantly less than the threshold, the MID threshold falls within
the CI but the median is still below that threshold</p></li>
<li><p>Probably clinically significant effect, the median crossed the MID
threshold but the threshold is still inside the CI</p></li>
<li><p>Large clinically significant effect, the median crossed the MID threshold
and the CI does not contain the threshold</p></li>
</ul><p>If a between group comparison is desired, a reference group can be defined
with the <code>reference_group</code> argument to which all subsequent groups are
compared. This is usually an inactive comparator such as a placebo or
wait-list control group. The difference between the pairwise compared
groups is categorized just as the within group difference above, so the
same categories apply.</p>
<p>The approach can be changed to a classical frequentist framework for which
the point estimate then represents the mean difference and the CI a
confidence interval. For an extensive overview over the differences between
a Bayesian and frequentist CI, refer to Hespanhol et al. (2019).</p>
    </div>
    <div class="section level2">
    <h2 id="data-preparation">Data preparation<a class="anchor" aria-label="anchor" href="#data-preparation"></a></h2>
    <p>The data set must be tidy, which corresponds to a
long data frame in general. It must contain a patient identifier which must
be unique per patient. Also, a column containing the different measurements
and the outcome must be supplied. Each participant-measurement combination
must be unique, so for instance, the data must not contain two "After"
measurements for the same patient.</p>
<p>Additionally, if the measurement column contains only two values, the first
value based on alphabetical, numerical or factor ordering will be used as
the <code>pre</code> measurement. For instance, if the column contains the
measurements identifiers <code>"pre"</code> and <code>"post"</code> as strings, then <code>"post"</code>
will be sorted before <code>"pre"</code> and thus be used as the <code>"pre"</code> measurement.
The function will throw a warning but generally you may want to explicitly
define the <code>"pre"</code> and <code>"post"</code> measurement with arguments <code>pre</code> and
<code>post</code>. In case of more than two measurement identifiers, you have to
define <code>pre</code> and <code>post</code> manually since the function does not know what your
pre and post intervention measurements are.</p>
<p>If your data is grouped, you can specify the group by referencing the
grouping variable (see examples below). The analysis is then run for every
group to compare group differences.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Hespanhol, L., Vallio, C. S., Costa, L. M., &amp; Saragiotto, B. T.
(2019). Understanding and interpreting confidence and credible intervals
around effect estimates. Brazilian Journal of Physical Therapy, 23(4),
290–301. https://doi.org/10.1016/j.bjpt.2018.12.006</p>
    </div>
    <div class="section level2">
    <h2 id="see-also">See also<a class="anchor" aria-label="anchor" href="#see-also"></a></h2>
    <div class="dont-index"><p>Main clinical signficance functions
<code><a href="cs_combined.html">cs_combined</a>()</code>,
<code><a href="cs_distribution.html">cs_distribution</a>()</code>,
<code><a href="cs_percentage.html">cs_percentage</a>()</code>,
<code><a href="cs_statistical.html">cs_statistical</a>()</code></p></div>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">cs_results</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span><span class="va">patient</span>, <span class="va">measurement</span>, <span class="va">mom_di</span>, mid_improvement <span class="op">=</span> <span class="fl">8</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> <span style="color: #00BBBB;">ℹ</span> Your "Before" was set as pre measurement and and your "After" as post.</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> <span style="color: #00BBBB;">•</span> If that is not correct, please specify the pre measurement with the argument</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span>   "pre".</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Individual anchor-based approach with a <span style="font-weight: bold;">8 point</span> decrease in instrument scores</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> indicating a clinical significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Category     |   n | Percent</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ----------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Improved     | 316 |  56.94%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Unchanged    | 175 |  31.53%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Deteriorated |  64 |  11.53%</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-1.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Set argument "pre" to avoid a warning</span></span></span>
<span class="r-in"><span><span class="va">cs_results</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    pre <span class="op">=</span> <span class="st">"Before"</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Inlcude the MID for deterioration</span></span></span>
<span class="r-in"><span><span class="va">cs_results_with_deterioration</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    pre <span class="op">=</span> <span class="st">"Before"</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span>,</span></span>
<span class="r-in"><span>    mid_deterioration <span class="op">=</span> <span class="fl">5</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results_with_deterioration</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Individual anchor-based approach with a <span style="font-weight: bold;">8 point</span> decrease in instrument scores</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> indicating a clinical significant improvement and a <span style="font-weight: bold;">5 point</span> increase in</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> instrument scores indicating a clinical significant deterioration.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Category     |   n | Percent</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ----------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Improved     | 316 |  56.94%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Unchanged    | 152 |  27.39%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Deteriorated |  87 |  15.68%</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">cs_results_with_deterioration</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Individual anchor-based analysis of clinical significance with a <span style="font-weight: bold;">8 point</span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> decrease in instrument scores (<span style="font-weight: bold;">mom_di</span>) indicating a clinical significant</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> improvement and a <span style="font-weight: bold;">5 point</span> increase in instrument scores indicating a clinical</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> significant deterioration.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> There were <span style="font-weight: bold;">555</span> participants in the whole dataset of which <span style="font-weight: bold;">555</span> <span style="font-weight: bold;">(100%)</span> could be</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> included in the analysis.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── Individual Level Results </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Category     |   n | Percent</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ----------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Improved     | 316 |  56.94%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Unchanged    | 152 |  27.39%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Deteriorated |  87 |  15.68%</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_with_deterioration</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-2.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Group the results by experimental condition</span></span></span>
<span class="r-in"><span><span class="va">cs_results_grouped</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    pre <span class="op">=</span> <span class="st">"Before"</span>,</span></span>
<span class="r-in"><span>    group <span class="op">=</span> <span class="va">condition</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span>,</span></span>
<span class="r-in"><span>    mid_deterioration <span class="op">=</span> <span class="fl">5</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results_grouped</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Individual anchor-based approach with a <span style="font-weight: bold;">8 point</span> decrease in instrument scores</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> indicating a clinical significant improvement and a <span style="font-weight: bold;">5 point</span> increase in</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> instrument scores indicating a clinical significant deterioration.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group            |     Category |   n | Percent</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -----------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        |     Improved |  27 |   4.86%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        |    Unchanged |  65 |  11.71%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        | Deteriorated |  60 |  10.81%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo |     Improved |  71 |  12.79%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo |    Unchanged |  41 |   7.39%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo | Deteriorated |  18 |   3.24%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   |     Improved |  98 |  17.66%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   |    Unchanged |  20 |   3.60%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   | Deteriorated |   3 |   0.54%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   |     Improved | 120 |  21.62%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   |    Unchanged |  26 |   4.68%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   | Deteriorated |   6 |   1.08%</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">cs_results_grouped</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Individual anchor-based analysis of clinical significance with a <span style="font-weight: bold;">8 point</span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> decrease in instrument scores (<span style="font-weight: bold;">mom_di</span>) indicating a clinical significant</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> improvement and a <span style="font-weight: bold;">5 point</span> increase in instrument scores indicating a clinical</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> significant deterioration.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> There were <span style="font-weight: bold;">555</span> participants in the whole dataset of which <span style="font-weight: bold;">555</span> <span style="font-weight: bold;">(100%)</span> could be</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> included in the analysis.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── Individual Level Results </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group            |     Category |   n | Percent</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -----------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        |     Improved |  27 |   4.86%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        |    Unchanged |  65 |  11.71%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        | Deteriorated |  60 |  10.81%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo |     Improved |  71 |  12.79%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo |    Unchanged |  41 |   7.39%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo | Deteriorated |  18 |   3.24%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   |     Improved |  98 |  17.66%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   |    Unchanged |  20 |   3.60%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   | Deteriorated |   3 |   0.54%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   |     Improved | 120 |  21.62%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   |    Unchanged |  26 |   4.68%</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   | Deteriorated |   6 |   1.08%</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_grouped</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-3.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># The plot method always returns a ggplot2 object, so the plot may be further</span></span></span>
<span class="r-in"><span><span class="co"># modified with ggplot2 code, e.g., facetting to avoid overplotting of groups</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_grouped</span><span class="op">)</span> <span class="op">+</span></span></span>
<span class="r-in"><span>  <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/facet_wrap.html" class="external-link">facet_wrap</a></span><span class="op">(</span><span class="op">~</span> <span class="va">group</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-4.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Compute group wise results</span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    pre <span class="op">=</span> <span class="st">"Before"</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span>,</span></span>
<span class="r-in"><span>    target <span class="op">=</span> <span class="st">"group"</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based approach (<span style="font-weight: bold;">within</span> groups) with a <span style="font-weight: bold;">8 point</span> decrease in</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> instrument scores indicating a clinical significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Median Difference | [Lower | Upper] | CI-Level | n   | Category                           </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -9.77             | -10.85 | -8.66  | 0.95     | 555 | Large clinically significant effect</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">cs_results_groupwise</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based analysis of clinical significance (<span style="font-weight: bold;">within</span> groups) with a</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> <span style="font-weight: bold;">8 point</span> decrease in instrument scores (<span style="font-weight: bold;">mom_di</span>) indicating a clinical</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> There were <span style="font-weight: bold;">555</span> participants in the whole dataset of which <span style="font-weight: bold;">555</span> <span style="font-weight: bold;">(100%)</span> could be</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> included in the analysis.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── Group Level Results </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Difference | [Lower | Upper] | CI-Level | n   | Category                           </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -----------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -9.77      | -10.85 | -8.66  | 0.95     | 555 | Large clinically significant effect</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_groupwise</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-5.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Group wise analysis, but split by experimentawl condition</span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise_condition</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    pre <span class="op">=</span> <span class="st">"Before"</span>,</span></span>
<span class="r-in"><span>    group <span class="op">=</span> <span class="va">condition</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span>,</span></span>
<span class="r-in"><span>    target <span class="op">=</span> <span class="st">"group"</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise_condition</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based approach (<span style="font-weight: bold;">within</span> groups) with a <span style="font-weight: bold;">8 point</span> decrease in</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> instrument scores indicating a clinical significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group            | Median Difference | [Lower | Upper] | CI-Level | n   | Category                                             </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -------------------------------------------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        | 1.82              | 0.22   | 3.40   | 0.95     | 152 | Statistically significant but not clinically relevant</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo | -9.36             | -11.43 | -7.28  | 0.95     | 130 | Probably clinically significant effect               </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   | -17.00            | -18.94 | -15.10 | 0.95     | 121 | Large clinically significant effect                  </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   | -15.80            | -17.55 | -14.06 | 0.95     | 152 | Large clinically significant effect                  </span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">cs_results_groupwise_condition</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based analysis of clinical significance (<span style="font-weight: bold;">within</span> groups) with a</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> <span style="font-weight: bold;">8 point</span> decrease in instrument scores (<span style="font-weight: bold;">mom_di</span>) indicating a clinical</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> There were <span style="font-weight: bold;">555</span> participants in the whole dataset of which <span style="font-weight: bold;">555</span> <span style="font-weight: bold;">(100%)</span> could be</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> included in the analysis.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── Group Level Results </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group            | Difference | [Lower | Upper] | CI-Level | n   | Category                                             </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ------------------------------------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List        | 1.82       | 0.22   | 3.40   | 0.95     | 152 | Statistically significant but not clinically relevant</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Inactive Placebo | -9.36      | -11.43 | -7.28  | 0.95     | 130 | Probably clinically significant effect               </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Active Placebo   | -17.00     | -18.94 | -15.10 | 0.95     | 121 | Large clinically significant effect                  </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Antidepressant   | -15.80     | -17.55 | -14.06 | 0.95     | 152 | Large clinically significant effect                  </span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_groupwise_condition</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-6.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Compare all groups to a predefined reference group at a predefined measurement</span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise_between</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    post <span class="op">=</span> <span class="st">"After"</span>,</span></span>
<span class="r-in"><span>    group <span class="op">=</span> <span class="va">condition</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span>,</span></span>
<span class="r-in"><span>    target <span class="op">=</span> <span class="st">"group"</span>,</span></span>
<span class="r-in"><span>    effect <span class="op">=</span> <span class="st">"between"</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise_between</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based approach (<span style="font-weight: bold;">between</span> groups) with a <span style="font-weight: bold;">8 point</span> decrease in</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> instrument scores indicating a clinical significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group 1   | Group 2          | Median Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                           </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -----------------------------------------------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Inactive Placebo | -11.68            | -13.33 | -10.12 | 0.95     | 152   | 130   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Active Placebo   | -17.72            | -19.49 | -15.90 | 0.95     | 152   | 121   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Antidepressant   | -18.46            | -20.23 | -16.81 | 0.95     | 152   | 152   | Large clinically significant effect</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">cs_results_groupwise_between</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based analysis of clinical significance (<span style="font-weight: bold;">between</span> groups) with</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> a <span style="font-weight: bold;">8 point</span> decrease in instrument scores (<span style="font-weight: bold;">mom_di</span>) indicating a clinical</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── Group Level Results </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group 1   | Group 2          | Median Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                           </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> -----------------------------------------------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Inactive Placebo | -11.68            | -13.33 | -10.12 | 0.95     | 152   | 130   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Active Placebo   | -17.72            | -19.49 | -15.90 | 0.95     | 152   | 121   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Antidepressant   | -18.46            | -20.23 | -16.81 | 0.95     | 152   | 152   | Large clinically significant effect</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_groupwise_between</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-7.png" alt="" width="700" height="433"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Compare all groups to a predefined reference group with frequentist appraoch</span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise_between_freq</span> <span class="op">&lt;-</span> <span class="va">antidepressants</span> <span class="op">|&gt;</span></span></span>
<span class="r-in"><span>  <span class="fu">cs_anchor</span><span class="op">(</span></span></span>
<span class="r-in"><span>    <span class="va">patient</span>,</span></span>
<span class="r-in"><span>    <span class="va">measurement</span>,</span></span>
<span class="r-in"><span>    <span class="va">mom_di</span>,</span></span>
<span class="r-in"><span>    post <span class="op">=</span> <span class="st">"After"</span>,</span></span>
<span class="r-in"><span>    group <span class="op">=</span> <span class="va">condition</span>,</span></span>
<span class="r-in"><span>    mid_improvement <span class="op">=</span> <span class="fl">8</span>,</span></span>
<span class="r-in"><span>    target <span class="op">=</span> <span class="st">"group"</span>,</span></span>
<span class="r-in"><span>    effect <span class="op">=</span> <span class="st">"between"</span>,</span></span>
<span class="r-in"><span>    bayesian <span class="op">=</span> <span class="cn">FALSE</span></span></span>
<span class="r-in"><span>  <span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">cs_results_groupwise_between_freq</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based approach (<span style="font-weight: bold;">between</span> groups) with a <span style="font-weight: bold;">8 point</span> decrease in</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> instrument scores indicating a clinical significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group 1   | Group 2          | Mean Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                           </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ---------------------------------------------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Inactive Placebo | -11.81          | -13.44 | -10.18 | 0.95     | 152   | 130   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Active Placebo   | -17.79          | -19.54 | -16.05 | 0.95     | 152   | 121   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Antidepressant   | -18.52          | -20.25 | -16.79 | 0.95     | 152   | 152   | Large clinically significant effect</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">cs_results_groupwise_between_freq</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── <span style="font-weight: bold;">Clinical Significance Results</span> ──</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Groupwise anchor-based analysis of clinical significance (<span style="font-weight: bold;">between</span> groups) with</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> a <span style="font-weight: bold;">8 point</span> decrease in instrument scores (<span style="font-weight: bold;">mom_di</span>) indicating a clinical</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> significant improvement.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ── Group Level Results </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Group 1   | Group 2          | Mean Difference | [Lower | Upper] | CI-Level | n (1) | n (2) | Category                           </span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> ---------------------------------------------------------------------------------------------------------------------------------</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Inactive Placebo | -11.81          | -13.44 | -10.18 | 0.95     | 152   | 130   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Active Placebo   | -17.79          | -19.54 | -16.05 | 0.95     | 152   | 121   | Large clinically significant effect</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Wait List | Antidepressant   | -18.52          | -20.25 | -16.79 | 0.95     | 152   | 152   | Large clinically significant effect</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">cs_results_groupwise_between_freq</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="cs_anchor-8.png" alt="" width="700" height="433"></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Benedikt Claus.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

